SEI Investments’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $555K | Buy |
+11,414
| New | +$555K | ﹤0.01% | 2140 |
|
2023
Q4 | – | Sell |
-55,455
| Closed | -$2.52M | – | 2623 |
|
2023
Q3 | $2.52M | Sell |
55,455
-2,414
| -4% | -$110K | ﹤0.01% | 1487 |
|
2023
Q2 | $3.25M | Sell |
57,869
-6,764
| -10% | -$380K | 0.01% | 1410 |
|
2023
Q1 | $2.92M | Buy |
+64,633
| New | +$2.92M | 0.01% | 1453 |
|
2022
Q4 | – | Sell |
-54,179
| Closed | -$3.54M | – | 2560 |
|
2022
Q3 | $3.54M | Buy |
54,179
+2,494
| +5% | +$163K | 0.01% | 1260 |
|
2022
Q2 | $3.14M | Buy |
+51,685
| New | +$3.14M | 0.01% | 1336 |
|
2022
Q1 | – | Sell |
-3,240
| Closed | -$247K | – | 2597 |
|
2021
Q4 | $247K | Sell |
3,240
-576
| -15% | -$43.9K | ﹤0.01% | 2401 |
|
2021
Q3 | $427K | Buy |
3,816
+642
| +20% | +$71.8K | ﹤0.01% | 2146 |
|
2021
Q2 | $514K | Buy |
3,174
+817
| +35% | +$132K | ﹤0.01% | 2080 |
|
2021
Q1 | $287K | Buy |
2,357
+256
| +12% | +$31.2K | ﹤0.01% | 2266 |
|
2020
Q4 | $322K | Buy |
+2,101
| New | +$322K | ﹤0.01% | 2177 |
|
2018
Q3 | – | Sell |
-800
| Closed | -$47K | – | 2648 |
|
2018
Q2 | $47K | Hold |
800
| – | – | ﹤0.01% | 2530 |
|
2018
Q1 | $37K | Buy |
+800
| New | +$37K | ﹤0.01% | 2451 |
|